• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIFESCAN EUROPE GMBH OT VERIO 2 METER; GLUCOSE MONITORING SYS/KIT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIFESCAN EUROPE GMBH OT VERIO 2 METER; GLUCOSE MONITORING SYS/KIT Back to Search Results
Model Number 022-657
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problems Dyspnea (1816); Blurred Vision (2137); Hot Flashes/Flushes (2153); Myalgia (2238); Confusion/ Disorientation (2553); Dry Mouth (4485)
Event Date 03/06/2022
Event Type  Injury  
Event Description
On (b)(6), 2022, the lay-user/patient¿s relative contacted lifescan (lfs) (b)(6), alleging that the patient¿s onetouch verio2 meter read inaccurately low.The complaint was classified based on the customer care agent (cca) documentation and on additional information obtained by the cca during a follow-up call with the reporter.The reporter stated that on the morning of (b)(6), 2022, the patient woke up with symptoms of ¿blurred vision, dry mouth, disorientation, body aches, redness and shortness of breath¿.During the follow-up call, the reporter related the symptoms to a high blood glucose excursion.In response to the symptoms, the reporter claimed the patient went directly to the emergency room (er), without measuring their blood glucose at home, and was hospitalized.The reporter confirmed the patient did not perform a blood glucose test with the subject meter that day.The reporter was unable to confirm if the patient¿s blood glucose was measured on arrival at er.The reporter informed the cca that the patient was hospitalized for 3 weeks because their diabetes was dysregulated.The reporter claimed that during hospitalization, it was necessary for the patient to have a computerised tomography scan performed and the use of the contrast for the scan, associated with diabetes, caused chronic kidney disease in the patient.In addition, the reporter claimed the patient had anaemia.The reporter stated that the patient was treated with insulin, blood bag and other unspecified drugs.The reporter claimed that on (b)(6), 2022, during hospitalization, the patient obtained blood glucose readings of ¿90 mg/dl¿ with the subject meter and ¿300 mg/dl¿ on the hospital meter (unspecified brand), performed within 30 minutes of each other.The reporter informed the cca that they suspected the subject meter had been reading inaccurate for a long time.The reporter claimed the patient¿s blood glucose averaged ¿100 mg/dl¿ with the subject meter which they felt was inaccurately low.During the initial call, the reporter indicated that prior to the onset of symptoms, the patient managed their diabetes with eucreas medication (unspecified dose) and claimed the patient had continued with their usual dose of medication in response to the alleged issue.During the follow-up call, the reporter felt that the incorrect blood glucose measurements with the subject meter contributed to the onset of the patient¿s symptoms.During troubleshooting, the cca confirmed the unit of measure was set correctly on the subject meter and that an approved sample site was used for testing.The cca confirmed the test strip vial was intact and the test strips had been stored correctly and were not expired or opened past their discard date.The cca noted the patient did not have control solution available to perform a quality control test.Replacement products were sent to the patient.This complaint is being reported because the patient reportedly developed symptoms suggestive of a serious injury adverse event requiring medical intervention while using the product.The subject meter could not be ruled out as a cause or contributor to the event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OT VERIO 2 METER
Type of Device
GLUCOSE MONITORING SYS/KIT
Manufacturer (Section D)
LIFESCAN EUROPE GMBH
gubelstrasse 34
zug 6300
SZ  6300
MDR Report Key13935057
MDR Text Key293711683
Report Number2939301-2022-03022
Device Sequence Number1
Product Code NBW
UDI-Device Identifier00353885008716
UDI-Public00353885008716
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Distributor
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 03/28/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/29/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model Number022-657
Device Catalogue Number022-657
Device Lot Number4604705
Was Device Available for Evaluation? No
Was the Report Sent to FDA? Yes
Distributor Facility Aware Date03/21/2022
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage A
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization; Life Threatening;
-
-